FDA | What's New Follow FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer Oncology Burst: FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer http://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dostarlimab-locally-advanced-rectal-cancer fda.gov
